Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,098 public trials 1,231 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Active, Not Recruiting

BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

NCT05120271

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations
  • Hoag Hospital Newport Beach Newport Beach, California, United States
  • Baylor Scott and White Research Institute Dallas, Texas, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Center - Seattle Cancer Care Alliance (SCCA) Location Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors

NCT06209567

Conditions
Brain Diseases, Brain Metastases, Brain Metastases, Adult, +15 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

NCT03897881

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • California Pacific Medical Center Research Institute -CPMCRI San Francisco, California, United States
  • Angeles Clinic and Research Institute Santa Monica, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors

NCT02743741

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Sunnybrook Odette Cancer Center Toronto, Ontario, Canada
View Trial Details

Related conditions